IceCure Medical/$ICCM
1D1W1MYTD1Y5YMAX
Capital at risk
About IceCure Medical
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
- Ticker
- $ICCM
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 68
- Headquarters
- Caesarea, Israel
- Website
- www.icecure-medical.com
IceCure Medical Metrics
BasicAdvanced
$7.3M
-
-$6.66
0.45
-
Price and volume
Market cap
$7.3M
Beta
0.45
52-week high
$6.55
52-week low
$1.55
Average daily volume
136K
Financial strength
Current ratio
2.875
Quick ratio
2.15
Long term debt to equity
0.002
Total debt to equity
0.008
Interest coverage (TTM)
-106.52%
Profitability
EBITDA (TTM)
-16.439
Gross margin (TTM)
36.10%
Net profit margin (TTM)
-427.67%
Operating margin (TTM)
-423.69%
Revenue per employee (TTM)
$60,000
Management effectiveness
Return on assets (TTM)
-73.88%
Return on equity (TTM)
-228.31%
Valuation
Price to revenue (TTM)
1.008
Price to book
0.45
Price to tangible book (TTM)
0.45
Price to free cash flow (TTM)
-0.25
Free cash flow yield (TTM)
-400.56%
Free cash flow per share (TTM)
-6.289
Growth
Revenue change (TTM)
41.62%
Earnings per share change (TTM)
-20.17%
3-year revenue growth (CAGR)
7.02%
10-year revenue growth (CAGR)
15.10%
3-year earnings per share growth (CAGR)
-16.28%
10-year earnings per share growth (CAGR)
-15.39%
IceCure Medical Financial Performance
Revenues and expenses
IceCure Medical Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.